Michael Kamal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Michael Kamal has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Gianni Parise
Department of Kinesiology McMaster University Hamilton Ontario Canada
6 shared publications - Mai Wageh
McMaster University
3 shared publications - Guillaume Paré
Population Health Research Institute, McMaster University, Hamilton, ON, Canada
2 shared publications - Jem L. Cheng
Vascular Dynamics Lab, Department of Kinesiology, McMaster University, Hamilton, Ontario, Canada
2 shared publications - Marie Pigeyre
15Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Canada
2 shared publications - Maureen Jane MacDonald
Department of Kinesiology, Faculty of Science McMaster University Hamilton Ontario Canada
2 shared publications
Latest Publications
- 5 November 2026
- Published by Wolters Kluwer Health in Circulation: Genomic and Precision Medicine
Genetic-Phenotypic Discordance Reveals Distinct Cardiovascular and Mortality Risk at HDL Cholesterol Extremes
BACKGROUND: Risk at high-density lipoprotein cholesterol (HDL-C) extremes may reflect genetic predisposition, ancestry, or region, but their relative contributions remain unknown. We characterized extreme HDL-C associations with atherosclerotic cardiovascular disease and mortality, and examined whether genetic-phenotypic discordance identifies risk beyond measured HDL-C. METHODS: Atherosclerotic cardiovascular disease–free participants from UKB (UK Biobank) and All of Us (AoU) with extremely low (2.3 mmol/L; based on standard clinical guidelines) HDL-C were analyzed. A 247-variant polygenic score stratified European ancestry participants at each HDL-C extreme into tertiles; discordant groups had measured HDL-C contradicting genetic predisposition. RESULTS: Among 408 353 UKB and 115 423 AoU participants, extremely low HDL-C was associated with higher atherosclerotic cardiovascular disease (UKB: hazard ratio [HR], 1.33 [95% CI, 1.27–1.39]; AoU: HR, 1.32 [95% CI, 1.08–1.61]) and mortality (UKB: HR, 1.25 [95% CI, 1.20–1.30]; AoU: HR, 1.64 [95% CI, 1.37–1.96]) across ancestries. Extremely high HDL-C was associated with excess mortality in UKB European ancestry (HR, 1.28 [95% CI, 1.19–1.38]), driven by COPD (HR, 2.64 [1.94–3.59]) and lung infections (HR, 2.24 [95% CI, 1.48–3.39]), but not in AoU European ancestry. In UKB, this was confined to genetically discordant high HDL (high-density lipoprotein; polygenic score HDL T1; HR, 1.53 [95% CI, 1.22–1.92]); genetically concordant high HDL showed progressively lower mortality. Genetically discordant low HDL (polygenic score HDL T3) carried higher atherosclerotic cardiovascular disease (UKB: HR, 1.20 [95% CI, 1.08–1.34]; AoU: HR, 1.44 [95% CI, 1.15–1.81]) and mortality (UKB: HR, 1.22 [95% CI, 1.11–1.34]; AoU: HR, 1.75 [95% CI, 1.21–2.54]) than concordant low HDL (polygenic score HDL T1), comparable in magnitude to a 10 mm Hg increment in systolic blood pressure. CONCLUSIONS: Extreme HDL-C levels carry different cardiovascular and mortality risk depending on whether they reflect or contradict genetic predisposition, with additional variation by ancestry and region.
- 5 November 2026
- Published by Wolters Kluwer Health in Circulation: Genomic and Precision Medicine
Genetic-Phenotypic Discordance Reveals Distinct Cardiovascular and Mortality Risk at HDL Cholesterol Extremes
BACKGROUND: Risk at high-density lipoprotein cholesterol (HDL-C) extremes may reflect genetic predisposition, ancestry, or region, but their relative contributions remain unknown. We characterized extreme HDL-C associations with atherosclerotic cardiovascular disease and mortality, and examined whether genetic-phenotypic discordance identifies risk beyond measured HDL-C. METHODS: Atherosclerotic cardiovascular disease–free participants from UKB (UK Biobank) and All of Us (AoU) with extremely low (2.3 mmol/L; based on standard clinical guidelines) HDL-C were analyzed. A 247-variant polygenic score stratified European ancestry participants at each HDL-C extreme into tertiles; discordant groups had measured HDL-C contradicting genetic predisposition. RESULTS: Among 408 353 UKB and 115 423 AoU participants, extremely low HDL-C was associated with higher atherosclerotic cardiovascular disease (UKB: hazard ratio [HR], 1.33 [95% CI, 1.27–1.39]; AoU: HR, 1.32 [95% CI, 1.08–1.61]) and mortality (UKB: HR, 1.25 [95% CI, 1.20–1.30]; AoU: HR, 1.64 [95% CI, 1.37–1.96]) across ancestries. Extremely high HDL-C was associated with excess mortality in UKB European ancestry (HR, 1.28 [95% CI, 1.19–1.38]), driven by COPD (HR, 2.64 [1.94–3.59]) and lung infections (HR, 2.24 [95% CI, 1.48–3.39]), but not in AoU European ancestry. In UKB, this was confined to genetically discordant high HDL (high-density lipoprotein; polygenic score HDL T1; HR, 1.53 [95% CI, 1.22–1.92]); genetically concordant high HDL showed progressively lower mortality. Genetically discordant low HDL (polygenic score HDL T3) carried higher atherosclerotic cardiovascular disease (UKB: HR, 1.20 [95% CI, 1.08–1.34]; AoU: HR, 1.44 [95% CI, 1.15–1.81]) and mortality (UKB: HR, 1.22 [95% CI, 1.11–1.34]; AoU: HR, 1.75 [95% CI, 1.21–2.54]) than concordant low HDL (polygenic score HDL T1), comparable in magnitude to a 10 mm Hg increment in systolic blood pressure. CONCLUSIONS: Extreme HDL-C levels carry different cardiovascular and mortality risk depending on whether they reflect or contradict genetic predisposition, with additional variation by ancestry and region.
- Open Access
Integrated multiomic scores for cardiovascular disease prediction across multiancestral populations
Background: Genomic, epigenomic, and proteomic data capture complementary aspects of cardiovascular disease biology, but the value of integrating these data for predicting multiple cardiovascular disease outcomes across ancestry groups remains uncertain. Methods: We derived disease-specific proteomic scores using 999 plasma proteins in 50,673 UK Biobank participants and validated them in 9,358 participants from the Prospective Urban and Rural Epidemiological (PURE) study. In PURE, we integrated these proteomic scores with 2,279 polygenic scores and 479 DNA methylation scores to develop 4 multiomic scores (MEGASCOREs) for myocardial infarction (MI), atrial fibrillation (AF), heart failure (HF), and cardiovascular mortality. Associations with incident cardiovascular disease, discrimination, calibration, and performance across ancestry groups were evaluated in PURE and 2 additional cohorts. Results: In pooled analyses, each standard deviation increase in the corresponding MEGASCORE was associated with MI (hazard ratio [HR], 2.13; 95% CI, 1.86-2.43), AF (HR, 1.94; 95% CI, 1.68-2.24), HF (HR, 3.33; 95% CI, 2.75-4.05), and cardiovascular mortality (HR, 3.28; 95% CI, 2.33-4.61). MEGASCOREs improved discrimination compared with clinical models, with strongest improvements for HF and cardiovascular mortality. MEGASCORE CV-Death had a higher area under the receiver operating characteristic curve (AUC) than SCORE2 for cardiovascular mortality (0.83 [95% CI, 0.82-0.85] vs. 0.78 [95% CI, 0.77-0.80]). Its discrimination was also higher than that of SCORE2 across all 4 ancestry groups, with better calibration across non-European ancestry groups. MEGASCOREs remained associated with cardiovascular outcomes among participants without conventional cardiovascular risk factors. Conclusions: Integrated multiomic MEGASCOREs were associated with multiple cardiovascular outcomes and provided prognostic information beyond conventional clinical variables in PURE. Clinical Perspective: What is new?: We developed 4 cardiovascular disease-specific multiomic scores integrating proteomic signatures, polygenic scores, and DNA methylation scores to characterize risk of MI, AF, HF, and cardiovascular mortality. The MEGASCOREs were associated with incident cardiovascular disease outcomes and provided prognostic information beyond conventional clinical risk factors. MEGASCOREs showed consistent risk stratification across ancestry and remained associated with risk among participants without conventional cardiovascular risk factors. What are the clinical implications?: Integrated multiomic scores may complement conventional cardiovascular risk assessment by capturing molecular information not fully represented by clinical variables. Molecular risk profiling may help identify individuals with elevated cardiovascular risk despite having no conventional risk factors. Assessment of clinical utility, evaluation of implementation and cost-effectiveness are needed before MEGASCOREs can inform preventive treatment decisions.
Open AccessIntegrated multiomic scores for cardiovascular disease prediction across multiancestral populations
Background: Genomic, epigenomic, and proteomic data capture complementary aspects of cardiovascular disease biology, but the value of integrating these data for predicting multiple cardiovascular disease outcomes across ancestry groups remains uncertain. Methods: We derived disease-specific proteomic scores using 999 plasma proteins in 50,673 UK Biobank participants and validated them in 9,358 participants from the Prospective Urban and Rural Epidemiological (PURE) study. In PURE, we integrated these proteomic scores with 2,279 polygenic scores and 479 DNA methylation scores to develop 4 multiomic scores (MEGASCOREs) for myocardial infarction (MI), atrial fibrillation (AF), heart failure (HF), and cardiovascular mortality. Associations with incident cardiovascular disease, discrimination, calibration, and performance across ancestry groups were evaluated in PURE and 2 additional cohorts. Results: In pooled analyses, each standard deviation increase in the corresponding MEGASCORE was associated with MI (hazard ratio [HR], 2.13; 95% CI, 1.86-2.43), AF (HR, 1.94; 95% CI, 1.68-2.24), HF (HR, 3.33; 95% CI, 2.75-4.05), and cardiovascular mortality (HR, 3.28; 95% CI, 2.33-4.61). MEGASCOREs improved discrimination compared with clinical models, with strongest improvements for HF and cardiovascular mortality. MEGASCORE CV-Death had a higher area under the receiver operating characteristic curve (AUC) than SCORE2 for cardiovascular mortality (0.83 [95% CI, 0.82-0.85] vs. 0.78 [95% CI, 0.77-0.80]). Its discrimination was also higher than that of SCORE2 across all 4 ancestry groups, with better calibration across non-European ancestry groups. MEGASCOREs remained associated with cardiovascular outcomes among participants without conventional cardiovascular risk factors. Conclusions: Integrated multiomic MEGASCOREs were associated with multiple cardiovascular outcomes and provided prognostic information beyond conventional clinical variables in PURE. Clinical Perspective: What is new?: We developed 4 cardiovascular disease-specific multiomic scores integrating proteomic signatures, polygenic scores, and DNA methylation scores to characterize risk of MI, AF, HF, and cardiovascular mortality. The MEGASCOREs were associated with incident cardiovascular disease outcomes and provided prognostic information beyond conventional clinical risk factors. MEGASCOREs showed consistent risk stratification across ancestry and remained associated with risk among participants without conventional cardiovascular risk factors. What are the clinical implications?: Integrated multiomic scores may complement conventional cardiovascular risk assessment by capturing molecular information not fully represented by clinical variables. Molecular risk profiling may help identify individuals with elevated cardiovascular risk despite having no conventional risk factors. Assessment of clinical utility, evaluation of implementation and cost-effectiveness are needed before MEGASCOREs can inform preventive treatment decisions.
- 1 July 2026
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 46 (7)
Arterial Shear Spectra Influence Endothelial Function and Are Regulated by Vascular Resistance
BACKGROUND: Biophysical interactions between forces exerted by blood and the vascular endothelium influence atherogenesis. The accurate characterization of these relationships, however, is obfuscated by the variety of metrics that exist to quantify arterial shear waveforms. Spectral analyses of these hemodynamic waveforms are an underutilized metric that may critically inform endothelial biology. This investigation, therefore, examined associations between shear spectral characteristics and endothelial function. METHODS: Arterial shear rate waveforms were recorded using Doppler ultrasonography from the brachial arteries of healthy humans. Spectral characteristics of the shear rate waveform were enumerated using Fourier transformations. Associations were explored between spectral characteristics and arterial function represented by brachial artery flow-mediated dilation calculated from the same anatomic site as waveform retrieval. Intracellular endothelial adaptations to different shear spectra were measured in vitro using cultured endothelial cells. Feature selection strategies were used to nominate hemodynamic mechanisms that may regulate the spectral characteristics of the brachial artery shear rate waveform. Vascular resistance was suggested as a candidate mechanism and was manipulated in 2 independent participant samples using local forearm heating and cooling and moderate-intensity continuous exercise. RESULTS: Positive associations were found between lower-frequency spectral amplitudes and brachial artery flow-mediated dilation. In cultured endothelial cells, lower-frequency spectra imparted an atheroprotective transcriptome measured by bulk RNA-sequencing. Fluorescence microscopy confirmed atheroprotective morphological and functional changes to endothelial cells exposed to lower-frequency shear. Vascular resistance was suggested as a hemodynamic mechanism that regulates shear rate spectra. Experimental manipulations of vascular resistance demonstrated that reductions in vascular resistance induce a leftward shift in shear spectra. Larger amplitudes of shear spectra were further observed among healthy humans compared with humans with atherosclerotic cardiovascular disease. CONCLUSIONS: Low-frequency characteristics extracted from the arterial shear rate waveform associate with decreases in peripheral vascular resistance and may impart atheroprotection in humans.
- 1 July 2026
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 46 (7)
Arterial Shear Spectra Influence Endothelial Function and Are Regulated by Vascular Resistance
BACKGROUND: Biophysical interactions between forces exerted by blood and the vascular endothelium influence atherogenesis. The accurate characterization of these relationships, however, is obfuscated by the variety of metrics that exist to quantify arterial shear waveforms. Spectral analyses of these hemodynamic waveforms are an underutilized metric that may critically inform endothelial biology. This investigation, therefore, examined associations between shear spectral characteristics and endothelial function. METHODS: Arterial shear rate waveforms were recorded using Doppler ultrasonography from the brachial arteries of healthy humans. Spectral characteristics of the shear rate waveform were enumerated using Fourier transformations. Associations were explored between spectral characteristics and arterial function represented by brachial artery flow-mediated dilation calculated from the same anatomic site as waveform retrieval. Intracellular endothelial adaptations to different shear spectra were measured in vitro using cultured endothelial cells. Feature selection strategies were used to nominate hemodynamic mechanisms that may regulate the spectral characteristics of the brachial artery shear rate waveform. Vascular resistance was suggested as a candidate mechanism and was manipulated in 2 independent participant samples using local forearm heating and cooling and moderate-intensity continuous exercise. RESULTS: Positive associations were found between lower-frequency spectral amplitudes and brachial artery flow-mediated dilation. In cultured endothelial cells, lower-frequency spectra imparted an atheroprotective transcriptome measured by bulk RNA-sequencing. Fluorescence microscopy confirmed atheroprotective morphological and functional changes to endothelial cells exposed to lower-frequency shear. Vascular resistance was suggested as a hemodynamic mechanism that regulates shear rate spectra. Experimental manipulations of vascular resistance demonstrated that reductions in vascular resistance induce a leftward shift in shear spectra. Larger amplitudes of shear spectra were further observed among healthy humans compared with humans with atherosclerotic cardiovascular disease. CONCLUSIONS: Low-frequency characteristics extracted from the arterial shear rate waveform associate with decreases in peripheral vascular resistance and may impart atheroprotection in humans.
- 1 May 2026
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 330 (5) , C1387-C1398
17β-Estradiol and progesterone have independent and combined effects on C2C12 myotubes following electrical pulse stimulation
17β-Estradiol (E2) and progesterone (P4) may differentially regulate myoblast function, with high concentrations suppressing proliferation. Notably, E2 enhances muscle repair after electrical stimulation, but P4 may influence this response when combined with E2 to simulate menstrual cycle phases. The discovery that ERα increases across all hormone treatments suggests a key regulatory role in muscle contractile responses. These findings provide novel insights into how menstrual cycle hormones may influence exercise recovery and muscle adaptation.
- 1 May 2026
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 330 (5) , C1387-C1398
17β-Estradiol and progesterone have independent and combined effects on C2C12 myotubes following electrical pulse stimulation
17β-Estradiol (E2) and progesterone (P4) may differentially regulate myoblast function, with high concentrations suppressing proliferation. Notably, E2 enhances muscle repair after electrical stimulation, but P4 may influence this response when combined with E2 to simulate menstrual cycle phases. The discovery that ERα increases across all hormone treatments suggests a key regulatory role in muscle contractile responses. These findings provide novel insights into how menstrual cycle hormones may influence exercise recovery and muscle adaptation.
- Open Access
- 26 April 2026
- Published by Wiley in Physiological Reports
- Vol. 14 (8) , e70886
Synthetic estrogen and progestin effects on the myogenic program following damage in C2C12 murine myoblasts
Females exhibit distinct responses to exercise‐induced muscle damage, possibly due to circulating hormone profiles. Despite the widespread use of oral contraceptives (OC) among females, the muscle damage and repair response during synthetic hormone use remains unknown. This study investigated how ethinyl estradiol (EE) and synthetic progestins [representing the different OC generations: medroxyprogesterone acetate (MPA), OC1; levonorgestrel (LNG), OC2; desogestrel (DSG), OC3; and drospirenone (DRP), OC4] influence C2C12 myoblast behavior. We examined proliferation, differentiation, and migration at baseline and following electrical pulse stimulation (EPS). While MPA and LNG alone increased myoblast proliferation (~19%; p < 0.05), their combination with EE (creating OC1 and OC2, respectively) reduced proliferation (15%–17%; p < 0.05) versus the vehicle control (VEH). All OC formulations significantly impaired migration (46%–61%; p < 0.001) without affecting differentiation. Post‐EPS, only OC1 and OC2 conditions showed elevated creatine kinase alongside upregulated early myogenic proteins and modulation of hormone receptors. These results indicate that synthetic sex hormones in OCs can significantly alter myoblast responses to damaging stimuli in a generation‐specific manner. OC use may influence muscle repair processes differently than natural hormonal profiles, highlighting the need for further investigation into how contraceptive formulations affect exercise recovery in women.
- 26 April 2026
- Published by Wiley in Physiological Reports
- Vol. 14 (8) , e70886
Open AccessSynthetic estrogen and progestin effects on the myogenic program following damage in C2C12 murine myoblasts
Females exhibit distinct responses to exercise‐induced muscle damage, possibly due to circulating hormone profiles. Despite the widespread use of oral contraceptives (OC) among females, the muscle damage and repair response during synthetic hormone use remains unknown. This study investigated how ethinyl estradiol (EE) and synthetic progestins [representing the different OC generations: medroxyprogesterone acetate (MPA), OC1; levonorgestrel (LNG), OC2; desogestrel (DSG), OC3; and drospirenone (DRP), OC4] influence C2C12 myoblast behavior. We examined proliferation, differentiation, and migration at baseline and following electrical pulse stimulation (EPS). While MPA and LNG alone increased myoblast proliferation (~19%; p < 0.05), their combination with EE (creating OC1 and OC2, respectively) reduced proliferation (15%–17%; p < 0.05) versus the vehicle control (VEH). All OC formulations significantly impaired migration (46%–61%; p < 0.001) without affecting differentiation. Post‐EPS, only OC1 and OC2 conditions showed elevated creatine kinase alongside upregulated early myogenic proteins and modulation of hormone receptors. These results indicate that synthetic sex hormones in OCs can significantly alter myoblast responses to damaging stimuli in a generation‐specific manner. OC use may influence muscle repair processes differently than natural hormonal profiles, highlighting the need for further investigation into how contraceptive formulations affect exercise recovery in women.
- Open Access
- 1 February 2025
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 328 (2) , C440-C451
Senescent myoblasts exhibit an altered exometabolome that is linked to senescence-associated secretory phenotype signaling
Cellular senescence and its accompanying secretory phenotype [i.e., the senescence-associated secretory phenotype (SASP)] have been linked to the aging-associated dysfunction of skeletal muscle, yet little is known about this phenomenon in satellite cells. We report that senescent myoblasts experience a significantly altered extracellular metabolome primarily characterized by the substantial release of nonesterified fatty acids. Targeted evaluation of several extracellular senescence-associated metabolites reveals a potential epigenetic role for long-chain fatty acids, particularly oleic acid, in regulating SASP-related gene expression.
- 1 February 2025
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 328 (2) , C440-C451
Open AccessSenescent myoblasts exhibit an altered exometabolome that is linked to senescence-associated secretory phenotype signaling
Cellular senescence and its accompanying secretory phenotype [i.e., the senescence-associated secretory phenotype (SASP)] have been linked to the aging-associated dysfunction of skeletal muscle, yet little is known about this phenomenon in satellite cells. We report that senescent myoblasts experience a significantly altered extracellular metabolome primarily characterized by the substantial release of nonesterified fatty acids. Targeted evaluation of several extracellular senescence-associated metabolites reveals a potential epigenetic role for long-chain fatty acids, particularly oleic acid, in regulating SASP-related gene expression.
- 1 October 2024
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 327 (4) , H1019-H1036
Menstrual and oral contraceptive pill cycles minimally influence vascular function and associated cellular regulation in premenopausal females
Comprehensive evaluation of the cardiovascular system in naturally cycling and second and third generation OCP users indicates no major influence of hormonal phases examined on endothelial function and smooth muscle function in the arteries of the upper and lower limbs, arterial stiffness, or underlying cellular mechanisms. Study findings challenge the historical exclusion of female participants due to potentially confounding hormonal cycles; researchers are encouraged to consider the hormonal environment in future study design.
- 1 October 2024
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 327 (4) , H1019-H1036
Menstrual and oral contraceptive pill cycles minimally influence vascular function and associated cellular regulation in premenopausal females
Comprehensive evaluation of the cardiovascular system in naturally cycling and second and third generation OCP users indicates no major influence of hormonal phases examined on endothelial function and smooth muscle function in the arteries of the upper and lower limbs, arterial stiffness, or underlying cellular mechanisms. Study findings challenge the historical exclusion of female participants due to potentially confounding hormonal cycles; researchers are encouraged to consider the hormonal environment in future study design.
- Open Access
- 30 September 2024
- Published by Wiley in Experimental Physiology
- Vol. 109 (11) , 1815-1816
Exercise is medicine, or exercise with medicine? Comparative effects on Na+,K+‐ATPase regulation
- 30 September 2024
- Published by Wiley in Experimental Physiology
- Vol. 109 (11) , 1815-1816
Open AccessExercise is medicine, or exercise with medicine? Comparative effects on Na+,K+‐ATPase regulation
- 10 January 2024
- Published by Wiley in The FASEB Journal
- Vol. 38 (2) , e23403
Nuclear‐localized androgen receptor content following resistance exercise training is associated with hypertrophy in males but not females
Androgen receptor (AR) content has been implicated in the differential response between high and low responders following resistance exercise training (RET). However, the influence of AR expression on acute skeletal muscle damage and whether it may influence the adaptive response to RET in females is poorly understood. Thus, the purpose of this exploratory examination was to 1) investigate changes in AR content during skeletal muscle repair and 2) characterize AR‐mediated sex‐based differences following RET. A skeletal muscle biopsy from the vastus lateralis was obtained from 26 healthy young men ( n = 13) and women ( n = 13) at baseline and following 300 eccentric kicks. Subsequently, participants performed 10 weeks of full‐body RET and a final muscle biopsy was collected. In the untrained state, AR mRNA expression was associated with paired box protein‐7 ( PAX7 ) mRNA in males. For the first time in human skeletal muscle, we quantified AR content in the myofiber and localized to the nucleus where AR has been shown to trigger cellular outcomes related to growth. Upon eccentric damage, nuclear‐associated AR (nAR) content increased ( p < .05) in males and not females. Males with the greatest increase in cross‐sectional area (CSA) post‐RET had more ( p < .05) nAR content than females with the greatest gain CSA. Collectively, skeletal muscle damage and RET increased AR protein, and both gene and hypertrophy measures revealed sex differences in relation to AR. These findings suggest that AR content but more importantly, nuclear localization, is a factor that differentiates RET‐induced hypertrophy between males and females.
- 10 January 2024
- Published by Wiley in The FASEB Journal
- Vol. 38 (2) , e23403
Nuclear‐localized androgen receptor content following resistance exercise training is associated with hypertrophy in males but not females
Androgen receptor (AR) content has been implicated in the differential response between high and low responders following resistance exercise training (RET). However, the influence of AR expression on acute skeletal muscle damage and whether it may influence the adaptive response to RET in females is poorly understood. Thus, the purpose of this exploratory examination was to 1) investigate changes in AR content during skeletal muscle repair and 2) characterize AR‐mediated sex‐based differences following RET. A skeletal muscle biopsy from the vastus lateralis was obtained from 26 healthy young men ( n = 13) and women ( n = 13) at baseline and following 300 eccentric kicks. Subsequently, participants performed 10 weeks of full‐body RET and a final muscle biopsy was collected. In the untrained state, AR mRNA expression was associated with paired box protein‐7 ( PAX7 ) mRNA in males. For the first time in human skeletal muscle, we quantified AR content in the myofiber and localized to the nucleus where AR has been shown to trigger cellular outcomes related to growth. Upon eccentric damage, nuclear‐associated AR (nAR) content increased ( p < .05) in males and not females. Males with the greatest increase in cross‐sectional area (CSA) post‐RET had more ( p < .05) nAR content than females with the greatest gain CSA. Collectively, skeletal muscle damage and RET increased AR protein, and both gene and hypertrophy measures revealed sex differences in relation to AR. These findings suggest that AR content but more importantly, nuclear localization, is a factor that differentiates RET‐induced hypertrophy between males and females.
- 26 September 2023
- Published by Springer Nature in GeroScience
- Vol. 46 (2) , 1843-1859
Bleomycin-treated myoblasts undergo p21-associated cellular senescence and have severely impaired differentiation
As we age, the ability to regenerate and repair skeletal muscle damage declines, partially due to increasing dysfunction of muscle resident stem cells—satellite cells (SC). Recent evidence implicates cellular senescence, which is the irreversible arrest of proliferation, as a potentiator of SC impairment during aging. However, little is known about the role of senescence in SC, and there is a large discrepancy in senescence classification within skeletal muscle. The purpose of this study was to develop a model of senescence in skeletal muscle myoblasts and identify how common senescence-associated biomarkers respond. Low-passage C2C12 myoblasts were treated with bleomycin or vehicle and then evaluated for cytological and molecular senescence markers, proliferation status, cell cycle kinetics, and differentiation potential. Bleomycin treatment caused double-stranded DNA breaks, which upregulated p21 mRNA and protein, potentially through NF-κB and senescence-associated super enhancer (SASE) signaling (p < 0.01). Consequently, cell proliferation was abruptly halted due to G2/M-phase arrest (p < 0.01). Bleomycin-treated myoblasts displayed greater senescence-associated β-galactosidase staining (p < 0.01), which increased over several days. These myoblasts remained senescent following 6 days of differentiation and had significant impairments in myotube formation (p < 0.01). Furthermore, our results show that senescence can be maintained despite the lack of p16 gene expression in C2C12 myoblasts. In conclusion, bleomycin treatment provides a valid model of damage-induced senescence that was associated with elevated p21, reduced myoblast proliferation, and aberrant cell cycle kinetics, while confirming that a multi-marker approach is needed for the accurate classification of senescence within skeletal muscle.
- 26 September 2023
- Published by Springer Nature in GeroScience
- Vol. 46 (2) , 1843-1859
Bleomycin-treated myoblasts undergo p21-associated cellular senescence and have severely impaired differentiation
As we age, the ability to regenerate and repair skeletal muscle damage declines, partially due to increasing dysfunction of muscle resident stem cells—satellite cells (SC). Recent evidence implicates cellular senescence, which is the irreversible arrest of proliferation, as a potentiator of SC impairment during aging. However, little is known about the role of senescence in SC, and there is a large discrepancy in senescence classification within skeletal muscle. The purpose of this study was to develop a model of senescence in skeletal muscle myoblasts and identify how common senescence-associated biomarkers respond. Low-passage C2C12 myoblasts were treated with bleomycin or vehicle and then evaluated for cytological and molecular senescence markers, proliferation status, cell cycle kinetics, and differentiation potential. Bleomycin treatment caused double-stranded DNA breaks, which upregulated p21 mRNA and protein, potentially through NF-κB and senescence-associated super enhancer (SASE) signaling (p < 0.01). Consequently, cell proliferation was abruptly halted due to G2/M-phase arrest (p < 0.01). Bleomycin-treated myoblasts displayed greater senescence-associated β-galactosidase staining (p < 0.01), which increased over several days. These myoblasts remained senescent following 6 days of differentiation and had significant impairments in myotube formation (p < 0.01). Furthermore, our results show that senescence can be maintained despite the lack of p16 gene expression in C2C12 myoblasts. In conclusion, bleomycin treatment provides a valid model of damage-induced senescence that was associated with elevated p21, reduced myoblast proliferation, and aberrant cell cycle kinetics, while confirming that a multi-marker approach is needed for the accurate classification of senescence within skeletal muscle.